| http://www.w3.org/ns/prov#value | - ase II RE-ALIGN trial, which tested three doses of the drug in patients with mechanical valves.Investigators stopped RE-ALIGN because patients on dabigatran experienced more adverse events such as strokes, heart attacks, and thrombus formation on mechanical heart valves compared with those taking warfarin.
|
